RhumbLine Advisers’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-24,451
Closed -$1.37M 2868
2016
Q4
$1.37M Buy
24,451
+1,372
+6% +$69.9K ﹤0.01% 1661
2016
Q3
$1.11M Buy
23,079
+1,110
+5% +$51.7K ﹤0.01% 1751
2016
Q2
$915K Sell
21,969
-72
-0.3% -$2.68K ﹤0.01% 1841
2016
Q1
$717K Buy
22,041
+1,375
+7% +$39.6K ﹤0.01% 1993
2015
Q4
$711K Buy
20,666
+1,495
+8% +$50.7K ﹤0.01% 2030
2015
Q3
$621K Buy
19,171
+845
+5% +$30.3K ﹤0.01% 2082
2015
Q2
$636K Sell
18,326
-1,315
-7% -$42.9K ﹤0.01% 2172
2015
Q1
$596K Buy
19,641
+5,300
+37% +$152K ﹤0.01% 2185
2014
Q4
$390K Buy
14,341
+425
+3% +$11.5K ﹤0.01% 2425
2014
Q3
$344K Buy
13,916
+75
+0.5% +$1.78K ﹤0.01% 2447
2014
Q2
$307K Sell
13,841
-170
-1% -$3.72K ﹤0.01% 2590
2014
Q1
$367K Sell
14,011
-800
-5% -$19.9K ﹤0.01% 2408
2013
Q4
$343K Hold
14,811
﹤0.01% 2507
2013
Q3
$249K Sell
14,811
-271
-2% -$4.39K ﹤0.01% 2658
2013
Q2
$222K Buy
+15,082
New +$237K ﹤0.01% 2914

Other funds holding VASC

RhumbLine Advisers's VASC Position: Q1 2017 in Review

RhumbLine Advisers sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 24,451 shares — an estimated $1.37M sold.

RhumbLine Advisers first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $1.37M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • RhumbLine Advisers reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • RhumbLine Advisers sold 24,451 Vascular Solutions Inc shares in Q1 2017, an estimated $1.37M.
  • RhumbLine Advisers first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
  • RhumbLine Advisers's Vascular Solutions Inc position peaked at $1.37M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.